Avon Products Inc (NYSE:AVP) Director W Don Cornwell bought 2,120 shares of Avon Products stock in a transaction that occurred on Thursday, May 8th. The shares were purchased at an average cost of $13.37 per share, with a total value of $28,344.40. Following the acquisition, the director now directly owns 11,883 shares in the company, valued at approximately $158,876. Avon Products, Inc. (NYSE:AVP) net profit margin is -0.70% and weekly performance is 0.22%. On last trading day company shares ended up $13.60. Analysts mean target price for the company is $18.13. Avon Products, Inc. (NYSE:AVP) distance from 50-day simple moving average (SMA50) is -7.46%.
AOL Inc (NYSE:AOL) CEO Timothy M. Armstrong purchased 55,600 shares of AOL stock in a transaction that occurred on Thursday, May 8th. The stock was purchased at an average cost of $36.08 per share, for a total transaction of $2,006,048.00. Following the completion of the purchase, the chief executive officer now directly owns 932,111 shares of the company’s stock, valued at approximately $33,630,565. AOL, Inc. (NYSE:AOL) shares advanced 3.71% in last trading session and ended the day on $37.74. Gross Margin is 26.50% and its return on assets is3.30%. AOL, Inc. (NYSE:AOL) quarterly performance is -20.18%.
Pitney Bowes (Inc NYSE:PBI) Director Stewart Hutcheson bought 5,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average cost of $26.02 per share, with a total value of $130,100.00. Following the completion of the purchase, the director now directly owns 14,256 shares in the company, valued at approximately $370,941. Pitney Bowes Inc. (NYSE:PBI) shares moved down -0.95% in last trading session and was closed at $25.94, while trading in range of $25.65 – 26.28 -. Pitney Bowes Inc. (NYSE:PBI) year to date (YTD) performance is 12.15%.
Opko Health Inc (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 33,900 shares of Opko Health stock in a transaction dated Tuesday, May 6th. The shares were purchased at an average cost of $8.24 per share, with a total value of $279,336.00. Following the completion of the purchase, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $16,377,000. Opko Health Inc. (NYSE:OPK) ended the last trading day at $8.24. Company weekly volatility is calculated as 3.87% and price to cash ratio as 18.34. Opko Health Inc. (NYSE:OPK) showed a negative weekly performance of-0.24%.
Leave a Reply